Doylestown researchers close in on hepatitis B treatment
Arbutus BioPharma Corp. expects to begin human testing on four possible hepatitis B treatments next year.
View ArticleShore hospital notifies patients they may have been exposed to HIV
Shore hospital notifies patients they may have been exposed to HIV
View ArticleFired pharmacist at center of scandal has 30-year history of addiction
The pharmacist at the center of a scandal potentially exposing 213 New Jersey hospital patients to HIV, hepatitis B and hepatitis C , has a long and tortured history of drug and alcohol abuse.
View ArticleThe thrill of curing hepatitis C and the pain of watching the disease surge...
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very common and because the hepatitis C virus had not yet been discovered. I...
View ArticleDentist's patients told to get tested for HIV and hepatitis
State officials have issued a notice to the former patients of Cotturo Dental Associates in the Lehigh Valley that they might be at risk due to unsanitary office practices.
View ArticleWhat to know about hepatitis A, B, and C
Three viruses—hepatitis A, hepatitis B, and hepatitis C—are the most common causes of liver inflammation.
View ArticleYour child's vaccines: What you need to know about catching up during the...
Immunization rates have dropped by 22% since the onset of the coronavirus pandemic. Many children have fallen behind on their vaccine schedules and parents have questions about how to catch them up.
View ArticlePeople under 25 account for nearly half of all new STI diagnoses, report shows
Some 26 million new sexually transmitted infections were diagnosed in 2018 — and nearly half of them were among people ages 15 to 24, according to a CDC analysis. About 20% of all Americans had an STI...
View Article